Logo

Clontech Acquisition Tops List of Most-Read GenomeWeb News Stories for Week Ended July 8

Jul 11, 2005

NEW YORK, July 11 (GenomeWeb News) - What are GenomeWeb News subscribers reading each week? Below are the five most-read articles for the five-day period ended Friday, July 8.

 

1. Japanese Biotech Takara Buys BD's Clontech Unit for $60M (from July 5)

2. Invitrogen is First Licensee Under ABI's 'Expanded' PCR Licensing Program (from July 5)

3. SGX Awarded $48.5 Million from NIH for Protein Structure Initiative Efforts (from July 4)

4. Castell to Retire from GE Healthcare; French Joins Sirna; Nanosphere Hires Shipp; Cash, Gene Codes Awarded Humanitarian Citation; and Others (from July 6)

5. Blue Heron to Supply Genes to Venter's New Synthetic Genomics Company (from July 7)

 

[This new GenomeWeb News feature will appear Monday mornings, or Tuesday if Monday falls on a US holiday. - Ed.]

Breaking News
The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.